Perigord adds 3millon euros in funding to drive market dominance in life science regulatory artwork software

Perigord, a Dublin based company specialised in artwork solutions for the pharma and life science industries, recorded 100% growth last year in its software division.

Blake Insomnia Therapeutics Inc. Announces Submitting Clinical Trial Application for Phase II Clinical Testing

Blake Insomnia Therapeutics Inc. , a New York based pharmaceutical company devoted to improving quality of life for people with insomnia, is excited to announce it has submitted its clinical trial application for Phase II...

AstraZeneca and Takeda establish collaboration to develop MEDI1341 for Parkinson disease

AstraZeneca and Takeda Pharmaceutical Company Limited announced that they have entered an agreement to jointly develop and commercialise MEDI1341, an alpha-synuclein antibody...

Solving Challenges and Pain Points for Complex Global Clinical Trials

Clinical trials are evolving away from trials based solely at investigator sites, moving on to the patients home, requiring direct-to-patient services in order for patients to participate.

Cmed to Demonstrate the Capture, Visualization and RTA of Clinical Data using encapsia at Mobile in Clinical Trials and DPharm 2017

Cmed has announced it will present its encapsia clinical data suite at Mobile in Clinical Trials and DPharm: Disruptive Innovations to Advance Clinical...

Oxford Genetics Secures 7.5 Million Pound  Investment

Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery,has announced a 7.5 million Euros investment into its operations in the US and the UK by Mercia Technologies PLC...

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2017 / Editorial Calender please click here

For the latest visit: www.worldpharmatoday.com